Cleared Special

K221443 - PureLift Pro Plus

K221443 is an FDA 510(k) clearance for PureLift Pro Plus, manufactured by Xtreem Pulse, LLC. The device is a Class 2 Neurology device with product code NFO cleared through the Special 510(k) pathway after a 156-day FDA review.

K221443 · Xtreem Pulse, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
156d
Days
Class 2
Risk

K221443 is an FDA 510(k) clearance for the PureLift Pro Plus. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Xtreem Pulse, LLC (New York, US). The FDA issued a Cleared decision on October 21, 2022 after a review of 156 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Xtreem Pulse, LLC devices

FDA 510(k) Submission Details - K221443

510(k) Number K221443 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 2022
Decision Date October 21, 2022
Days to Decision 156 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 148d · This submission: 156d
Pathway characteristics
Modification to existing cleared device.

NFO Device Classification - Class 2, Special Controls

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 53
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K221443.
Medi Lift PLUS
K220198 · Ya-Man, Ltd. · Jun 2023
PureLift Pro Edition
K230506 · Xtreem Pulse · Jun 2023
Myolift QT
K213078 · Johari Digital Healthcare Limited · Apr 2023
Luminice
K214100 · Premier North America, Inc. · Feb 2022
Microcurrent device (Model: HBR2-1)
K211055 · Shenzhen DJ Medical Equipment Co., Ltd. · Nov 2021
TheraFace Microcurrent
K212238 · Theragun, Inc. · Sep 2021